fundraising >
Loading...
Loading investors...
16,370 investors
16,370 investors |
Geography | Checks | Stages | Lead | Investment thesis | Value add | Typical terms | Socials | Reply rate | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
![]() | Hakluyt Capital VC firm | USA | N/A | 4. Scaling | We invest in high-growth companies, partnering with prominent venture capital funds. |
|
Send email
| ||||
![]() | Gruppo Cordifin | Italy | N/A | 2. Prototype | We invest in manufacturing, industrial, and real estate companies. |
|
Send email
| ||||
![]() | TNN Capital VC firm | USA | N/A | 3. Early Revenue | We invest in financial services. |
|
Send email
| ||||
![]() | JB Ventures VC firm | Hong Kong South Korea | N/A | 3. Early Revenue 4. Scaling | Sometimes | We invest in startups, providing venture capital and accelerator support. |
|
Send email
| |||
![]() | Innovations and Te... VC firm | Slovakia | N/A | 3. Early Revenue | We invest in seed and startup. |
|
Send email
| ||||
![]() | Synergy Ventures | USA | $250k to $1M | 3. Early Revenue | We invest in start-up companies developing medical device and diagnostic products that address major diseases and conditions prevalent in industrialized countries as the population ages (such as cancer, cardiovascular and neurological diseases, orthopedic problems, respiratory conditions, and gastrointestinal disorders).
In these areas, we favor companies with novel, single-use medical devices that can provide clinically efficacious therapy, at lower cost, and with manageable and acceptable regulatory and reimbursement risks.
We look for start-up ventures featuring product concepts that can be advanced with minimal infrastructure and head-count – companies that can demonstrate clinical efficacy of their product or technology early on, and thus create strong potential for partnerships and acquisitions.
Synergy also assists our portfolio companies in developing corporate partnerships in Japan at the appropriate time, which can also provide significant strategic and economic benefits. Our LPs are major Japan medical device corporations. |
|
Send email
| ||||
![]() | Ignite 500 VC firm | UK | N/A | 3. Early Revenue | We invest in blockchain, AI, and healthcare technology. |
|
Send email
| ||||
![]() | Paddock Capital VC firm | Canada | N/A | 3. Early Revenue 4. Scaling | We invest in mid-market financial services organizations. |
|
Send email
| ||||
![]() | Neu Venture Capita... VC firm | Canada USA | $50k to $200k | 2. Prototype 3. Early Revenue4. Scaling | Never | We invest in data visualization, machine learning, and analytics. |
|
| |||
![]() | Epsilon Health Inv... VC firm | USA | N/A | 3. Early Revenue 4. Scaling5. Growth | Sometimes | We invest in the healthcare sector. |
|
Send email
| |||
![]() | Maskinongé MRC Public fund | Canada | N/A | 3. Early Revenue | We invest in civic tech, govtech, and smart cities initiatives. |
|
Send email
| ||||
![]() | D2 Digital Venture VC firm | Lithuania | N/A | 3. Early Revenue | We invest in digital. |
|
Send email
| ||||
![]() | Twin Apex Capital | India Israel Singapore UK | N/A | 3. Early Revenue | Sometimes | We invest in blockchain and crypto assets and projects. |
|
Send email
| |||
![]() | Renaissance KMU Sc... | Romania Switzerland | N/A | 5. Growth 3. Early Revenue | We invest directly in unlisted companies with high growth potential across various sectors. |
|
Send email
| ||||
![]() | Hydra Ventures | USA | N/A | 3. Early Revenue | We invest in seed-stage and other growing companies. |
|
Send email
| ||||
![]() | fourteen17 VC firm | UK | N/A | 4. Scaling | We invest in entrepreneurs and emerging businesses, providing capital for growth. |
|
Send email
| ||||
![]() | Kitara Capital VC firm | India | N/A | 4. Scaling 3. Early Revenue | Sometimes | We invest in companies at seed, growth, and later stages, offering private equity and venture capital. |
|
Send email
| |||
![]() | Innovative Enterta... VC firm | USA | N/A | 4. Scaling | We invest in energy. |
|
Send email
| ||||
![]() | PNP Investment VC firm | Cyprus South Korea | N/A | 3. Early Revenue 4. Scaling | Never | We invest as a venture capital funding platform. |
|
Send email
| |||
![]() | Hongkai Investment VC firm | China | N/A | 3. Early Revenue 4. Scaling | We invest in companies related to asset management and consulting. |
|
Send email
| ||||

USA
Italy

Hong Kong
South Korea
Slovakia


UK
Canada



Lithuania
India
Israel
Singapore
Romania
Switzerland




Cyprus
China